FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/01/2024 |
3. Issuer Name and Ticker or Trading Symbol
EAGLE MATERIALS INC [ EXP ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 3,105(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Non-Qualified Stock Option (Right to Buy) | (2) | 06/13/2032 | Common Stock | 2,199 | $118.27 | D | |
Restricted Stock Units | (3) | (3) | Common Stock | 946.0133(4) | (5) | D |
Explanation of Responses: |
1. This number includes the following restricted shares: (a) 1,268 shares remaining from a grant awarded to the reporting person on 6/13/2022, the restrictions on which will lapse ratably on June 13 of 2025 and 2026; and (b) 800 shares remaining from a grant awarded to the reporting person on 5/23/2023, the restrictions on which will lapse ratably on March 31 of 2025 and 2026. |
2. On June 13, 2022 the reporting person was granted an option to purchase up to 2,199 shares of Common Stock. Currently, 1,100 options are exercisable and the remaining options will vest ratably on June 13 of 2025 and 2026. |
3. The restricted stock units vest ratably in three installments on May 24, 2025; on March 31, 2026; and on March 31, 2027. |
4. Represents 945 restricted stock units awarded to the reporting person on May 24, 2024, plus accrued dividend equivalent restricted stock units accrued in connection with a cash dividend paid by Issuer on its Common Stock. |
5. Each restricted stock unit represents a contingent right to receive one share of EXP common stock. |
/s/ Scott M. Wilson as Attorney-in-Fact for Alex Haddock | 08/07/2024 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |